Broad-Based MedSurg Growth Likely to Aid MDT's Q4 Performance
Medtronic's Q4 results may get a lift from broad MedSurg growth, strong Cardiovascular demand and continued momentum in Diabetes.
Zacks
More News
Here's Why Pediatrix Medical Group (MD) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
Here's Why You Should Add Pediatrix Medical to Your Portfolio Now
MD gains from stronger cash collections, payer mix and acquisitions, while telehealth expansion and buybacks support growth.
Zacks
Mizuho Lifts PT on Pediatrix Medical Group (MD) Following Q1 Results
Mizuho Lifts PT on Pediatrix Medical Group (MD) Following Q1 Results...
Yahoo! Finance: News
Why Pediatrix Medical Group (MD) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
Pediatrix Medical Q1 Earnings Beat Estimates on Same-Unit Strength
Pediatrix Medical Group tops Q1 estimates as stronger reimbursements and same-unit gains lift results despite lower patient volumes.
Zacks
Pediatrix Medical Group (NYSE:MD) Issues Earnings Results, Beats Expectations By $0.07 EPS
Pediatrix Medical Group (NYSE:MD - Get Free Report) issued its quarterly earnings data on Tuesday. The company reported $0.44 EPS for the quarter, beating the consensus estimate of $0.37 by $0.07...
MarketBeat
Pediatrix Medical Group (NYSE:MD) Shares Gap Down - Here's What Happened
Pediatrix Medical Group (NYSE:MD) Shares Gap Down - What's Next...
MarketBeat
Transcript: Pediatrix Medical Group Q1 2026 Earnings Conference Call
read more...
Benzinga
Pediatrix Medical Group (MD) Q1 Earnings and Revenues Surpass Estimates
Pediatrix Medical Group (MD) delivered earnings and revenue surprises of +19.73% and +1.97%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?